These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cefonicid kinetics in subjects with normal and impaired renal function. Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031 [TBL] [Abstract][Full Text] [Related]
5. Cefmenoxime pharmacokinetics in patients with renal insufficiency. Polk RE; Sica DA; Kerkering TM; Kline BJ; Patterson PM; Baggett JW Antimicrob Agents Chemother; 1984 Sep; 26(3):322-7. PubMed ID: 6095752 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of carumonam in patients with renal insufficiency. Horber F; Egger HJ; Weidekamm E; Dubach UC; Frey FJ; Probst PJ; Stoeckel K Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324 [TBL] [Abstract][Full Text] [Related]
7. Disposition of minoxidil in patients with various degrees of renal function. Halstenson CE; Opsahl JA; Wright CE; Fleishaker JC; Andreadis NA; Sobieraj J; Matzke GR J Clin Pharmacol; 1989 Sep; 29(9):798-802. PubMed ID: 2808745 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ceftazidime in patients with renal insufficiency. Welage LS; Schultz RW; Schentag JJ Antimicrob Agents Chemother; 1984 Feb; 25(2):201-4. PubMed ID: 6370127 [TBL] [Abstract][Full Text] [Related]
9. Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function. St Peter JV; Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE Antimicrob Agents Chemother; 1992 Jan; 36(1):126-31. PubMed ID: 1590677 [TBL] [Abstract][Full Text] [Related]
10. Disposition of guanadrel in subjects with normal and impaired renal function. Halstenson CE; Opsahl JA; Abraham PA; Schwenk MH; Andreadis NA; Antal EJ; Matzke GR J Clin Pharmacol; 1989 Feb; 29(2):128-32. PubMed ID: 2715368 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction. Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JW Antimicrob Agents Chemother; 1991 Sep; 35(9):1879-83. PubMed ID: 1952862 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Leroy A; Humbert G; Fillastre JP Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects. Shah A; Lettieri J; Blum R; Millikin S; Sica D; Heller AH J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis. Blum RA; Kohli RK; Harrison NJ; Schentag JJ Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ceftazidime in normal and uremic subjects. Leroy A; Leguy F; Borsa F; Spencer GR; Fillastre JP; Humbert G Antimicrob Agents Chemother; 1984 May; 25(5):638-42. PubMed ID: 6375562 [TBL] [Abstract][Full Text] [Related]
18. Cefsulodin pharmacokinetics during hemodialysis. Matzke GR; Keane WF Trans Am Soc Artif Intern Organs; 1982; 28():324-8. PubMed ID: 7164256 [No Abstract] [Full Text] [Related]
19. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Kneer J; Tam YK; Blouin RA; Frey FJ; Keller E; Stathakis C; Luginbuehl B; Stoeckel K Antimicrob Agents Chemother; 1989 Nov; 33(11):1952-7. PubMed ID: 2610506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]